SLF1081851
SLF1081851 is a Spns2 inhibitor, inhibits S1P release (IC50=1.93 μM) . SLF1081851 plays a key role in development and immune system[1][2].
Product Specifications
CAS Number
[2763730-97-6]
UNSPSC
12352005
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/slf1081851.html
Purity
98.02
Solubility
Ethanol : 10 mg/mL (ultrasonic)
Smiles
NCCCC1=NC(C2=CC=C(CCCCCCCCCC)C=C2)=NO1
Molecular Formula
C21H33N3O
Molecular Weight
343.51
References & Citations
[1]Russell Fritzemeier, et al. Discovery of In Vivo Active Sphingosine-1-phosphate Transporter (Spns2) Inhibitors. J Med Chem. 2022 Jun 9;65 (11) :7656-7681
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6121501-01 0.2 mL
FUCA2 (FUCA2, Plasma alpha-L-fucosidase, Alpha-L-fucoside fucohydrolase 2) (Azide free) (HRP)
Ask
View Details MBS6121501-02 5x 0.2 mL
FUCA2 (FUCA2, Plasma alpha-L-fucosidase, Alpha-L-fucoside fucohydrolase 2) (Azide free) (HRP)
Ask
View Details